1-4 of 4
Nathan De Beule, MD
Close
Sort by
Journal Articles

Receptor Tyrosine Kinase AXL: A Potential Strategy to Counter Immune Suppression and Dormancy in Multiple Myeloma

Kim De Veirman, Siyang Yan, Ken Maes, Nathan De Beule, MD, Sylvia Faict, MSc, Elke De Bruyne, PhD, Eline Menu, PhD, Karin Vanderkerken, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4335.
https://doi.org/10.1182/blood-2019-126834
Published: 2019
Journal Articles

Targeting S100A9 Interactions in the Multiple Myeloma Bone Marrow Environment Reduces Angiogenesis and Tumor Growth

Kim De Veirman, PhD, Els Van Valckenborgh, PhD, Nathan De Beule, MD, Hendrik De Raeve, Ken Maes, PhD, Elke De Bruyne, PhD, Eline Menu, PhD, Karin Vanderkerken, PhD
Journal: Blood
Blood (2016) 128 (22): 3248.
https://doi.org/10.1182/blood.V128.22.3248.3248
Published: 2016
Journal Articles

Long-Term Survival and Quality of Life Analysis after Autologous Stem Cell Transplantation for Lymphoma

Sylvia Faict, MD, Nathan De Beule, MD, Ann De Becker, MD, Karel Fostier, MD, Fabienne Trullemans, MD, Henri (Rik) Schots, MD PhD
Journal: Blood
Blood (2016) 128 (22): 2268.
https://doi.org/10.1182/blood.V128.22.2268.2268
Published: 2016
Journal Articles

Bone Marrow Stromal Cell-Derived Exosomes Facilitate Multiple Myeloma Cell Survival Through Inhibition Of The JNK Pathway

Jinheng Wang, An Hendrix, PhD, Elke De Bruyne, PhD, Els Van Valckenborgh, PhD, Eddy Himpe, Nathan De Beule, MD, Olivier De Wever, PhD, Karin Vanderkerken, Eline Menu, PhD
Journal: Blood
Blood (2013) 122 (21): 679.
https://doi.org/10.1182/blood.V122.21.679.679
Published: 2013